View Cart (0 items)

Pharmaceutical

J&J In Talks to Buy Swiss Company Synthes for $20 Billion

April 18, 2011
Reuters reports, Johnson & Johnson is in preliminary talks to acquire Swiss medical device maker Synthes for a price, which could be about $20 billion, a source familiar with the
Read More

GlaxoSmithKline to Invest £500 Million in Egypt Healthcare

April 11, 2011
Daily News Egypt reports, GlaxoSmithKline Consumer Healthcare announced they will invest approximately £ 500 million in Egypt’s healthcare sector. “Our main goal over the next five years is to
Read More

Pfizer Selling Capsugel Unit for $2.38 Billion

April 4, 2011
Reuters reports, Pfizer Inc has struck a deal to sell its Capsugel unit, the world''s largest maker of hard capsules, to private equity firm KKR & Co for nearly $2.38
Read More

Materia Plans Singapore-Based Catalyst Manufacturing Facility

March 21, 2011
In a press release, Materia announced its plans for opening a catalyst manufacturing and R&D facility in Singapore. The company expects to complete the site selection process in 3Q 2011
Read More

Bafna Pharma to Acquire Raricap from J&J

March 21, 2011
Pharmaceutical Business Review reports, Bafna Pharmaceuticals, a Chennai, India-based contract research manufacturer, plans to buy Raricap from Johnson & Johnson for INR210m. Raricap, which contains calcium, folic acid and iron,
Read More

Feds Takes Over Three Tylenol Plants

March 14, 2011
CNNMoney reports, the U.S. Government is taking over three Tylenol plants following a blizzard of drug recalls and a Food and Drug Administration criminal investigation into safety issues at
Read More

Japan Halts Vaccines After Deaths of Four Children

March 7, 2011
The Associated Press reports, Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were
Read More

Targacept, GlaxoSmithKline End Partnership

March 3, 2011
The Associated Press reports, Targacept Inc. and GlaxoSmithKline announced they are ending their partnership to develop treatments for addiction, obesity, and several other conditions. In a statement, Targacept noted that
Read More

Genzyme Expects Writedown for Layoffs, Up to $23 Million

February 21, 2011
The Associated Press reports, Genzyme Corp. said it expects a new round of layoffs to result in charges of $16 million to $23 million. Genzyme, which is being acquired by
Read More

More Outsourcing Planned for FDA Overseas Inspections

February 14, 2011
According to Bloomberg, U.S. regulators plan to outsource more inspections of overseas factories within the next decade after criticism from Congress about a lack of oversight for food and drugs
Read More